Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice

INTRODUCTION: The treatment of choice for Atypical Hemolytic Uremic Syndrome (aHUS) is the monoclonal antibody eculizumab. The objective of this study was to assess the efficacy and safety of eculizumab in a cohort of kidney transplant patients suffering from aHUS. METHODS: Description of the prospe...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: de Andrade, Luis Gustavo Modelli, Contti, Mariana Moraes, Nga, Hong Si, Bravin, Ariane Moyses, Takase, Henrique Mochida, Viero, Rosa Marlene, da Silva, Trycia Nunes, Chagas, Kelem De Nardi, Palma, Lilian Monteiro Pereira
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2017
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685617/
https://ncbi.nlm.nih.gov/pubmed/29136640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188155
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker